{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:50:11Z","timestamp":1762419011997,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.remnie.2023.12.002","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T07:06:26Z","timestamp":1702710386000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding polymyalgia rheumatica, the role of Nuclear Medicine Imaging"],"prefix":"10.1016","volume":"43","author":[{"given":"E.","family":"Noriega-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rodr\u00edguez-Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Merino Argum\u00e1nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Dom\u00ednguez Gadea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Peir\u00f3-Valga\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2023.12.002_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.remnie.2023.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s40266-019-00705-5","article-title":"Pathogenesis, diagnosis and management of polymyalgia rheumatica","volume":"36","author":"Camellino","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0015","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/ijerph20031789","article-title":"Differentiating between seronegative elderly-onset rheumatoid arthritis and polymyalgia rheumatica: a qualitative synthesis of narrative reviews","volume":"20","author":"Ohta","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.remnie.2023.12.002_bib0020","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.remnie.2023.12.002_bib0025","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.remnie.2023.12.002_bib0030","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1136\/annrheumdis-2015-207395","article-title":"Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids","volume":"74","author":"Mackie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.remnie.2023.12.002_bib0035","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"Schmidt","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.remnie.2023.12.002_bib0040","first-page":"519","article-title":"Joint imaging in polymyalgia rheumatica","volume":"51","author":"O\u2019Duffy","year":"1976","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.remnie.2023.12.002_bib0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40336-021-00445-w","article-title":"State of the art of 18F-FDG PET\/CT application in inflammation and infection: a guide for image acquisition and interpretation","volume":"9","author":"Casali","year":"2021","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00296-023-05284-8","article-title":"Imaging methods in polymyalgia rheumatica: a systematic review","volume":"43","author":"Mekenyan","year":"2023","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.remnie.2023.12.002_bib0055","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/keq450","article-title":"Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis","volume":"51","author":"Camellino","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.remnie.2023.12.002_bib0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.55563\/clinexprheumatol\/5qmpcb","article-title":"Imaging in polymyalgia rheumatica: which technique to use?","volume":"39","author":"Figus","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.remnie.2023.12.002_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.1070445","article-title":"18F-FDG PET molecular imaging: a relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?","volume":"9","author":"Pean De Ponfilly-Sotier","year":"2022","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.remnie.2023.12.002_bib0075","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170198","article-title":"18F-FDG PET\/CT in polymyalgia rheumatica-a pictorial review","volume":"90","author":"Rehak","year":"2017","journal-title":"Br J Radiol."},{"key":"10.1016\/j.remnie.2023.12.002_bib0080","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keab483","article-title":"Comparison and validation of FDG-PET\/CT scores for polymyalgia rheumatica","volume":"61","author":"Van Der Geest","year":"2022","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.remnie.2023.12.002_bib0085","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/rheumatology\/kex376","article-title":"Use of 18f-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica \u2014 A prospective study of 99 patients","volume":"57","author":"Henckaerts","year":"2018","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.remnie.2023.12.002_bib0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.rlu.0000259570.69163.04","article-title":"Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans","volume":"32","author":"Parysow","year":"2007","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remnie.2023.12.002_bib0095","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00259-013-2569-6","article-title":"Optimizing 18F-FDG PET\/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels","volume":"41","author":"Bucerius","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41927-020-00121-y","article-title":"18F-fluorodeoxyglucose\u2013positron emission tomography\/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study","volume":"4","author":"Horikoshi","year":"2020","journal-title":"BMC Rheumatology"},{"key":"10.1016\/j.remnie.2023.12.002_bib0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/joim.13525","article-title":"An update on polymyalgia rheumatica","volume":"292","author":"Lundberg","year":"2022","journal-title":"J Inter Med"},{"key":"10.1016\/j.remnie.2023.12.002_bib0120","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keaa646","article-title":"New insights into the role of imaging in polymyalgia rheumatica","volume":"60","author":"Camellino","year":"2021","journal-title":"Rheumatology (United Kingdom)"},{"key":"10.1016\/j.remnie.2023.12.002_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/rg.2020190047","article-title":"Fluorodeoxyglucose PET\/CT of arthritis in rheumatic diseases: a pictorial review","volume":"40","author":"Hotta","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.remnie.2023.12.002_bib0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/14397595.2014.978936","article-title":"Differences in fluorodeoxyglucose positron emission tomography\/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica","volume":"25","author":"Takahashi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.remnie.2023.12.002_bib0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.semnuclmed.2022.08.010","article-title":"Update on imaging of inflammatory arthritis and related disorders","volume":"53","author":"Jamar","year":"2023","journal-title":"Seminars in Nuclear Medicine"},{"key":"10.1016\/j.remnie.2023.12.002_bib0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2014.06.004","article-title":"Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis","volume":"44","author":"Ungprasert","year":"2014","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.remnie.2023.12.002_bib0145","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.3390\/jcm12082844","article-title":"Usefulness of 18F-fluorodeoxyglucose positron emission tomography in diagnosing polymyalgia rheumatica and large-vessel vasculitis: a case-control study","volume":"12","author":"Desvages","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.remnie.2023.12.002_bib0150","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/jcm10163704","article-title":"Imaging tests in the early diagnosis of giant cell arteritis","volume":"10","author":"Prieto-Pe\u00f1a","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.remnie.2023.12.002_bib0155","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4067\/s0034-98872021000500773","article-title":"PET-CT FDG en el diagn\u00f3stico y seguimiento de vasculitis de grandes vasos","volume":"149","author":"Vicentela","year":"2021","journal-title":"Rev m\u00e9d Chile"},{"key":"10.1016\/j.remnie.2023.12.002_bib0160","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2169\/internalmedicine.1847-18","article-title":"Paraneoplastic syndrome presenting with polymyalgia rheumatica-like accumulations on 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography","volume":"58","author":"Umetsu","year":"2019","journal-title":"Intern Med"},{"key":"10.1016\/j.remnie.2023.12.002_bib0165","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1093\/rheumatology\/keac125","article-title":"The role of PET\/CT in disease activity assessment in patients with large vessel vasculitis","volume":"61","author":"Galli","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.remnie.2023.12.002_bib0170","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12081961","article-title":"Imaging Findings in patients with immune checkpoint inhibitor-induced arthritis","volume":"12","author":"Ponce","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.remnie.2023.12.002_bib0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/annrheumdis-2012-202883","article-title":"Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis","volume":"73","author":"Corbera-Bellalta","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.remnie.2023.12.002_bib0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.remnie.2023.12.002_bib0185","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00259-015-3287-z","article-title":"Value of 18F-FDG PET\/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment","volume":"43","author":"Palard-Novello","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.12.002_bib0195","first-page":"288","article-title":"Methotrexate treatment of polymyalgia rheumatica\/giant cell arteritis-associated large vessel vasculitis","volume":"28","author":"Camellino","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.remnie.2023.12.002_bib0200","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/rheumatology\/keaa080","article-title":"Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis","volume":"59","author":"Wadstr\u00f6m","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:45:21Z","timestamp":1762418721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808923000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2253808923000976"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2023.12.002","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding polymyalgia rheumatica, the role of Nuclear Medicine Imaging","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2023.11.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}